These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 28745767)
21. Which Dendrimer to Attain the Desired Properties? Focus on Phosphorhydrazone Dendrimers. Caminade AM; Majoral JP Molecules; 2018 Mar; 23(3):. PubMed ID: 29522459 [TBL] [Abstract][Full Text] [Related]
22. Time evolution of the aggregation process of peptides involved in neurodegenerative diseases and preventing aggregation effect of phosphorus dendrimers studied by EPR. Ottaviani MF; Mazzeo R; Cangiotti M; Fiorani L; Majoral JP; Caminade AM; Pedziwiatr E; Bryszewska M; Klajnert B Biomacromolecules; 2010 Nov; 11(11):3014-21. PubMed ID: 20958001 [TBL] [Abstract][Full Text] [Related]
23. Dendrimers in the context of nanomedicine. Dias AP; da Silva Santos S; da Silva JV; Parise-Filho R; Igne Ferreira E; Seoud OE; Giarolla J Int J Pharm; 2020 Jan; 573():118814. PubMed ID: 31759101 [TBL] [Abstract][Full Text] [Related]
24. Exploration of biomedical dendrimer space based on in-vitro physicochemical parameters: key factor analysis (Part 1). Mignani S; Rodrigues J; Roy R; Shi X; Ceña V; El Kazzouli S; Majoral JP Drug Discov Today; 2019 May; 24(5):1176-1183. PubMed ID: 30898662 [TBL] [Abstract][Full Text] [Related]
26. Dendrimers for theranostic applications. Sk UH; Kojima C Biomol Concepts; 2015 Jun; 6(3):205-17. PubMed ID: 26136305 [TBL] [Abstract][Full Text] [Related]
27. Neutral high-generation phosphorus dendrimers inhibit macrophage-mediated inflammatory response in vitro and in vivo. Posadas I; Romero-Castillo L; El Brahmi N; Manzanares D; Mignani S; Majoral JP; Ceña V Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7660-E7669. PubMed ID: 28847956 [TBL] [Abstract][Full Text] [Related]
28. Bioinspired therapeutic dendrimers as efficient peptide drugs based on supramolecular interactions for tumor inhibition. Zhang X; Zhang Z; Xu X; Li Y; Li Y; Jian Y; Gu Z Angew Chem Int Ed Engl; 2015 Mar; 54(14):4289-94. PubMed ID: 25727937 [TBL] [Abstract][Full Text] [Related]
29. Effect of viologen-phosphorus dendrimers on acetylcholinesterase and butyrylcholinesterase activities. Ciepluch K; Weber M; Katir N; Caminade AM; El Kadib A; Klajnert B; Majoral JP; Bryszewska M Int J Biol Macromol; 2013 Mar; 54():119-24. PubMed ID: 23237795 [TBL] [Abstract][Full Text] [Related]
30. Binding of poly(amidoamine), carbosilane, phosphorus and hybrid dendrimers to thrombin-Constants and mechanisms. Shcharbin D; Pedziwiatr-Werbicka E; Vcherashniaya A; Janaszewska A; Marcinkowska M; Goska P; Klajnert-Maculewicz B; Ionov M; Abashkin V; Ihnatsyeu-Kachan A; de la Mata FJ; Ortega P; Gomez-Ramirez R; Majoral JP; Bryszewska M Colloids Surf B Biointerfaces; 2017 Jul; 155():11-16. PubMed ID: 28388470 [TBL] [Abstract][Full Text] [Related]
31. Effect of phosphorus dendrimers on DMPC lipid membranes. Ionov M; Wróbel D; Gardikis K; Hatziantoniou S; Demetzos C; Majoral JP; Klajnert B; Bryszewska M Chem Phys Lipids; 2012 May; 165(4):408-13. PubMed ID: 22173018 [TBL] [Abstract][Full Text] [Related]
32. Original Multivalent Gold(III) and Dual Gold(III)-Copper(II) Conjugated Phosphorus Dendrimers as Potent Antitumoral and Antimicrobial Agents. Mignani SM; El Brahmi N; El Kazzouli S; Laurent R; Ladeira S; Caminade AM; Pedziwiatr-Werbicka E; Szewczyk EM; Bryszewska M; Bousmina MM; Cresteil T; Majoral JP Mol Pharm; 2017 Nov; 14(11):4087-4097. PubMed ID: 28960997 [TBL] [Abstract][Full Text] [Related]
33. Dendrimers as Innovative Radiopharmaceuticals in Cancer Radionanotherapy. Liko F; Hindré F; Fernandez-Megia E Biomacromolecules; 2016 Oct; 17(10):3103-3114. PubMed ID: 27608327 [TBL] [Abstract][Full Text] [Related]
34. In vitro PAMAM, phosphorus and viologen-phosphorus dendrimers prevent rotenone-induced cell damage. Milowska K; Szwed A; Zablocka M; Caminade AM; Majoral JP; Mignani S; Gabryelak T; Bryszewska M Int J Pharm; 2014 Oct; 474(1-2):42-9. PubMed ID: 25108046 [TBL] [Abstract][Full Text] [Related]
35. Enhanced catalytic properties of copper in O- and N-arylation and vinylation reactions, using phosphorus dendrimers as ligands. Ouali A; Laurent R; Caminade AM; Majoral JP; Taillefer M J Am Chem Soc; 2006 Dec; 128(50):15990-1. PubMed ID: 17165724 [TBL] [Abstract][Full Text] [Related]
36. Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications. Kannan RM; Nance E; Kannan S; Tomalia DA J Intern Med; 2014 Dec; 276(6):579-617. PubMed ID: 24995512 [TBL] [Abstract][Full Text] [Related]
37. Interaction of cationic phosphorus dendrimers (CPD) with charged and neutral lipid membranes. Ionov M; Gardikis K; Wróbel D; Hatziantoniou S; Mourelatou H; Majoral JP; Klajnert B; Bryszewska M; Demetzos C Colloids Surf B Biointerfaces; 2011 Jan; 82(1):8-12. PubMed ID: 20846836 [TBL] [Abstract][Full Text] [Related]
38. Raman spectroscopy study of phosphorus-containing dendrimers built from thiophosphoryl core. Furer VL; Vandyukov AE; Majoral JP; Caminade AM; Kovalenko VI Spectrochim Acta A Mol Biomol Spectrosc; 2010 Jul; 76(2):276-82. PubMed ID: 20399138 [TBL] [Abstract][Full Text] [Related]
39. Dendrimer-nanoparticle conjugates in nanomedicine. Parat A; Bordeianu C; Dib H; Garofalo A; Walter A; Bégin-Colin S; Felder-Flesch D Nanomedicine (Lond); 2015; 10(6):977-92. PubMed ID: 25867861 [TBL] [Abstract][Full Text] [Related]
40. Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. Bharali DJ; Khalil M; Gurbuz M; Simone TM; Mousa SA Int J Nanomedicine; 2009; 4():1-7. PubMed ID: 19421366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]